Jun 27, 2025 04:06PM Pliant Therapeutics Inc. (PLRX) Provides Update on BEACON-IPF

May 21, 2025 04:03PM Pliant Therapeutics (PLRX) Presents Clinical and Preclinical Data at the American Thoracic Society International Conference

May 8, 2025 07:36PM Pliant Therapeutics, Inc. (PLRX) Misses Q1 EPS by 15c

May 1, 2025 04:18PM Pliant Therapeutics (PLRX) Announces Strategic Realignment of Workforce and Operations

Apr 1, 2025 07:44PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Mar 21, 2025 09:15AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - PLRX

Mar 17, 2025 02:26PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Mar 17, 2025 08:00AM Pliant Therapeutics (PLRX) Reports Interim Phase 1 Data for PLN-101095

Mar 13, 2025 07:20AM Pliant Therapeutics (PLRX) Adopts Limited Duration Stockholder Rights Agreement

Mar 11, 2025 10:12AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Mar 7, 2025 10:20AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics

Mar 4, 2025 04:34AM Pliant Therapeutics (PLRX) PT Lowered to $1.50 at Citi

Mar 4, 2025 03:20AM Cantor Fitzgerald Reinstates Pliant Therapeutics (PLRX) at Neutral

Mar 3, 2025 05:17PM Pliant Therapeutics, Inc. (PLRX) Tops Q4 EPS by 17c

Mar 3, 2025 02:21PM Stifel Downgrades Pliant Therapeutics (PLRX) to Hold

Mar 3, 2025 01:08PM Leerink Partners Downgrades Pliant Therapeutics (PLRX) to Market Perform, 'We await clarity on what that path forward would look like'

Mar 3, 2025 09:27AM Pliant Therapeutics (PLRX) Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis

Feb 13, 2025 09:11AM Stifel Reiterates Buy Rating on Pliant Therapeutics (PLRX), PT $32

Feb 13, 2025 08:04AM Pliant Therapeutics Inc. (PLRX) Announces Next Steps Following DSMB Recommendation on BEACON-IPF

Feb 10, 2025 08:58AM JPMorgan Downgrades Pliant Therapeutics (PLRX) to Neutral

Feb 10, 2025 07:35AM Pliant Therapeutics (PLRX) PT Lowered to $10 at Needham

Feb 10, 2025 06:04AM H.C. Wainwright Downgrades Pliant Therapeutics (PLRX) to Neutral

Feb 10, 2025 06:03AM Oppenheimer Downgrades Pliant Therapeutics (PLRX) to Perform

Feb 10, 2025 05:13AM Pliant Therapeutics Inc. (PLRX) call put ratio 7.1 calls to 1 put into pauses enrollment, dosing in BEACON-IPF Phase 2b trial

Feb 10, 2025 03:19AM Wells Fargo Downgrades Pliant Therapeutics (PLRX) to Equal Weight

Feb 10, 2025 03:15AM Citi Downgrades Pliant Therapeutics (PLRX) to Neutral

Feb 7, 2025 05:01PM Pliant Therapeutics Inc. (PLRX) Provides Update on BEACON-IPF

Jan 22, 2025 08:06AM Pliant Therapeutics Inc. (PLRX) Appoints Delphine Imbert as Chief Technical Officer

Nov 11, 2024 08:35AM H.C. Wainwright Reiterates Buy Rating on Pliant Therapeutics (PLRX)

Nov 8, 2024 01:08PM Stifel Reiterates Buy Rating on Pliant Therapeutics (PLRX)

Nov 8, 2024 06:26AM Pliant Therapeutics, Inc. (PLRX) Tops Q3 EPS by 2c

Oct 17, 2024 08:02AM Pliant Therapeutics (PLRX) INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting 2024

Oct 1, 2024 04:36PM Pliant Therapeutics (PLRX) Appoints Gary Palmer as SVP of Medical Affairs

Sep 24, 2024 08:02AM Aligos Therapeutics (ALGS) Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer

Sep 17, 2024 07:19AM Piper Sandler Reiterates Overweight Rating on Pliant Therapeutics (PLRX)

Sep 13, 2024 06:43AM H.C. Wainwright Reiterates Buy Rating on Pliant Therapeutics (PLRX)

Sep 9, 2024 12:08PM Leerink Partners Assumes Pliant Therapeutics (PLRX) at Outperform, 'we see strong strategic optionality for PLRX'

Aug 8, 2024 09:30AM Stifel Reiterates Buy Rating on Pliant Therapeutics (PLRX)

Aug 8, 2024 04:08AM Pliant Therapeutics, Inc. (PLRX) Misses Q2 EPS by 7c

Jul 16, 2024 10:53AM H.C. Wainwright Reiterates Buy Rating on Pliant Therapeutics (PLRX)

Jul 16, 2024 07:23AM TD Cowen Reiterates Buy Rating on Pliant Therapeutics (PLRX)

Jul 15, 2024 08:00AM Pliant Therapeutics Inc. (PLRX) Reports Positive Long-Term Data from the INTEGRIS-PSC Phase 2a Trial

Jun 13, 2024 04:08PM Pliant Therapeutics (PLRX) Appoints Steve Krognes to its Board